Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Acute Thoraco-Lumbar Spinal Cord Injury
NCT07272967Phase 4Not yet recruiting
- Sponsor
- Badr University in Cairo
- Start
- Jan 2026
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in spinal cord injury (SCI), sponsored by Badr University in Cairo. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT07272967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07272967.